Medicine and Dentistry
Acute Heart Infarction
71%
Amphotericin
23%
Antibiotic Resistance
23%
Cardiac Marker
23%
Cardiometabolic Risk
23%
Cardiovascular Disease
62%
Cardiovascular System
47%
Congestive Heart Failure
35%
COVID-19
47%
Diabetes
42%
Diabetology
47%
Disability Adjusted Life Years
24%
Diseases
47%
DNA Extraction
11%
Dysglycemia
15%
Dyslipidemia
23%
Echinocandin
23%
Empagliflozin
50%
End-Diastolic Volume
15%
End-Systolic Volume
15%
Exenatide
23%
Fluconazole
23%
Global Disease Burden
51%
Glomerular Filtration Rate
23%
Health Care
23%
Heart Left Ventricle Ejection Fraction
15%
Hematology
11%
Hemoglobin A1c
23%
Infection Control
23%
Intensive Care Unit
23%
Intermittent Fasting
23%
Ketone Bodies
23%
Left Ventricle
23%
Maturity Onset Diabetes of the Young
64%
Metabolic Syndrome
47%
Mouthwash
11%
Multidrug Resistance
23%
Musculoskeletal Disease
23%
Non Communicable Disease
35%
Odds Ratio
15%
Percutaneous Coronary Intervention
13%
Placebo
12%
Post-Hoc Analysis
23%
Prevalence
46%
Prospective Cohort Study
23%
Pyrrole Derivative
23%
Randomized Controlled Trial
23%
SEQUEST
23%
Sodium Glucose Cotransporter 2 Inhibitor
36%
Systematic Review
23%
Pharmacology, Toxicology and Pharmaceutical Science
25 Hydroxyvitamin D
23%
3 Hydroxybutyric Acid
5%
Acute Heart Infarction
71%
Amphotericin
5%
Antimicrobial Resistance
11%
Brain Natriuretic Peptide
11%
Candida
11%
Candida Auris
23%
Cardiovascular Disease
95%
Cardiovascular Risk
14%
Cohort Study
23%
Comorbidity
32%
Congestive Heart Failure
38%
COVID-19 Vaccine
23%
Disease Course
6%
Diseases
36%
Dysglycemia
15%
Dyslipidemia
33%
Echinocandin
5%
Empagliflozin
61%
Exendin 4
47%
Fluconazole
5%
Global Disease Burden
79%
Hemoglobin A1c
26%
High Density Lipoprotein Cholesterol
6%
Hypoglycemia
7%
Hypovitaminosis D
23%
Infection
5%
Ischemic Heart Disease
7%
Ketone Bodies
23%
Life Expectancy
10%
Low Back Pain
35%
Low Density Lipoprotein Cholesterol
6%
Messenger RNA
23%
Multidrug Resistance
5%
Musculoskeletal Disease
23%
Newborn Disease
7%
Non Communicable Disease
36%
Non Insulin Dependent Diabetes Mellitus
100%
Pandemic
23%
Placebo
18%
Prematurity
7%
Prevalence
86%
Pyrrole Derivative
5%
Randomized Controlled Trial
23%
Respiratory Tract
5%
Respiratory Tract Infection
15%
Sodium Glucose Cotransporter 2 Inhibitor
45%
Vitamin D
17%
Vitamin D Deficiency
23%
Nursing and Health Professions
3 Hydroxybutyric Acid
5%
Acute Heart Infarction
23%
Adverse Event
9%
Anthropometry
12%
Blood Analysis
7%
Blood Pressure Measurement
7%
Brain Natriuretic Peptide
11%
Cardiovascular Disease
95%
Cardiovascular Risk
14%
Central Obesity
36%
Congestive Heart Failure
5%
Dysglycemia
31%
Dyslipidemia
57%
Empagliflozin
23%
Exendin 4
23%
Family History
7%
Health Care Personnel
23%
Healthcare System
23%
Heart Left Ventricle Ejection Fraction
23%
Heart Left Ventricle Enddiastolic Volume
23%
Heart Left Ventricle Filling Pressure
5%
High Density Lipoprotein Cholesterol
6%
Ketone Bodies
23%
Low Density Lipoprotein Cholesterol
6%
Metabolic Syndrome X
23%
Non Communicable Disease
12%
Odds Ratio
15%
Patient with Type 2 Diabetes
23%
Pharmacovigilance
23%
Placebo
11%
Post Hoc Analysis
23%
Prevalence
23%
Proportional Hazards Model
6%
Receiver Operating Characteristic
10%
Sodium Glucose Cotransporter 2 Inhibitor
17%
Study Participant
7%
Systematic Review
23%
Systolic Blood Pressure
13%
Volunteer
12%